Skip to Content

Join the 'Gastrointestinal Stromal Tumor' group to help and get support from people like you.

Gastrointestinal Stromal Tumor News

FDA Approves Stivarga for Advanced Gastrointestinal Stromal Tumors

Posted 25 Feb 2013 by

February 25, 2013 – The U.S. Food and Drug Administration today expanded the approved use of Stivarga (regorafenib) to treat patients with advanced gastrointestinal stromal tumors (GIST) that cannot be surgically removed and no longer respond to other FDA-approved treatments for this disease. GIST is a tumor in which cancerous cells form in the tissues of the gastrointestinal tract, part of the ...

Gastrointestinal Tumor Patients Live Longer on Cancer Drug

Posted 28 Mar 2012 by

WEDNESDAY, March 28 – Extended treatment with the cancer drug Gleevec leads to improved survival rates in patients who have had surgery to remove a gastrointestinal stromal tumor and have a high risk of cancer recurrence, a new study says. "Gastrointestinal stromal tumors are usually found in the stomach or the small intestine but can occur at any site along the gastrointestinal tract and rarely ...

Staying on Gleevec Seems to Help Gastro Cancer Patients

Posted 22 Sep 2010 by

TUESDAY, Sept. 21 – Continuous treatment with imatinib (Gleevec) is recommended for patients with advanced gastrointestinal cancer, a new study suggests. The study included 50 patients with advanced gastrointestinal stromal tumors (GIST) who'd been receiving Gleevec for three years and had no disease progression. The patients were randomly selected to either continue or stop treatment. The ...

Researchers Zero In on GI Cancers

Posted 14 Jan 2009 by

WEDNESDAY, Jan. 14 – New research may one day help physicians identify those patients with gastrointestinal cancers who are most likely to benefit from certain treatments. The discoveries, paving the way toward an era of personalized medicine, could save the U.S. health-care system millions while sparing patients the agony of receiving treatments that aren't going to help them. "These are a ...

Gleevec Approved for Use After Cancer Surgery

Posted 22 Dec 2008 by

MONDAY, Dec. 22 – Gleevec, a "miracle drug" in curing certain types of adult leukemia, has received U.S. Food and Drug Administration approval to stop cancer growth after gastrointestinal cancer surgery. According to an FDA news release, Gleevec (imatinib mesylate) can be used after removal of a gastrointestinal stromal tumor (GIST). While this is a fairly rare form of cancer (5,000 - 6,000 new ...

Gleevec Prevents Return of Intestinal Cancer, Study Confirms

Posted 19 Mar 2009 by

THURSDAY, March 19 – Taking Gleevec after surgery to remove a gastrointestinal stromal tumor improves tumor-free survival, a U.S. study has confirmed. Gastrointestinal stromal tumors (GIST), the most common soft-tissue cancer of the intestinal tract, typically occur in the stomach or small intestine. About 3,000 to 4,000 cases are diagnosed in the United States each year. According to background ...

Ask a Question

Further Information

Related Condition Support Groups

Gastrointestinal Disorders

Related Drug Support Groups

Gleevec, Sutent, imatinib, Stivarga, sunitinib, regorafenib